sphingosine 1-phosphate receptor subtype-2 antagonists (Bridge)

N/A

Report date: 2025/01/26 18:06:53
NME

Base Information

Drug Namesphingosine 1-phosphate receptor subtype-2 antagonists (Bridge)
Drug Alias Namesphingosine 1-phosphate receptor subtype-2 antagonists (Weill Cornell Medicine/Bridge)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine 1-phosphate receptor 2 antagonists
TargetsSphingosine 1-phosphate receptor 2
Therapy Area/IndicationsFibrosisVascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWeill Medical College of Cornell University
China Registration ClassN/A

Develop Information

Active CompaniesBridge Medicines Inc
Inactive CompaniesWeill Medical College of Cornell UniversityTri-Institutional Therapeutics Discovery Institute
Active IndicationsFibrosisVascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A